Searched for
RALOXIFENE HYDROCHLORIDE
Small-cap stocks: Riskier, yes, but if picked well, risk-reward ratio favours risk-takers; 6 small-caps with upside potential of up to 45%The Q3 earnings season is likely to provide some positive surprises as it will reflect the full impact of the GST rate rejig and the softer...- Small-cap stocks: A 7-point checklist for better returns; 8 small-caps with an upside potential of up to 46%When investing in stock markets, it’s crucial to make a distinction between high-quality and poor-quality businesses across the small-, mid...
- After long phase of consolidation: 4 Indian pharma stocks with upside potential of up to 41%Between 2005 to 2015, the pharma sector was one of the best performing sectors with stocks creating big wealth for the shareholders. Then c...
- New tailwinds emerge! 5 midcap pharma stocks with upside potential of up to 37%If one looks at corporate announcements, a large number of small and mid-caps pharma companies are announcing one or the other thing either...
- Medicine for bearish markets: 5 Indian pharma stocks with upside potential of up to 32%There are some sectors which are able to face bears in a better way. The reason, the operating matrix of those sectors is such that rising ...
- Second & better attempt; 5 Indian pharma stocks with upside potential of up to 31%Both, in terms of bottomline and stock price performance, pharma stocks had been under pressure for a long time. Partly this under performa...
- Sensex rangebound, Nifty holds 8,000; Escorts up 6%, OBC 4%The S&P BSE Sensex slipped over 100 points in trade on Monday following muted trend seen in other Asian markets.
- Aurobindo Pharma gains on USFDA approval for generic osteoporosis drugShares of Aurobindo Pharma gained 3.3 per cent in trade on Monday, after the company got US FDA nod for generic osteoporosis drug.
- Fourteen stocks in focus in Monday's tradeIndian markets are expected to trade lower. Here is a list of fourteen stocks which are likely to remain in focus today.
- Aurobindo Pharma gets US FDA nod for generic osteoporosis drugAurobindo Pharma has received approval from the US FDA to manufacture and market its generic version of Eli Lilly's Evista tablets used to ...
Load More
